New Key Statistics Module, Z-Score and F-Score
OTCPK:SOLTF Key Ratios
Market Cap $ M | 830.80 |
Enterprise Value $ M | 970.29 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | 49.46 |
Price/Book | 1.73 |
Price/Sales | 4.94 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 155.00 |
EPS (TTM) $ | -0.77 |
Beneish M-Score | -1.53 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -200.40 |
EV-to-EBIT | -18.84 |
EV-to-EBITDA | -38.25 |
PEG | -- |
Shares Outstanding M | 89.90 |
Net Margin (%) | -42.14 |
Operating Margin % | -38.61 |
Pre-tax Margin (%) | -43.18 |
Quick Ratio | 3.96 |
Current Ratio | 4.11 |
ROA % (ttm) | -6.84 |
ROE % (ttm) | -15.26 |
ROIC % (ttm) | -9.72 |
Dividend Yield % | -- |
Altman Z-Score | 1.00 |
SOLTF Number of Guru Trades
SOLTF Volume of Guru Trades
Gurus Latest Trades with OTCPK:SOLTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SOLTF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Nxera Pharma Co Ltd Insider Transactions
No Available Data
News about OTCPK:SOLTF
Total 0- 1